Prevalence of Diabetes in India: A Review of IDF Diabetes Atlas 10th Edition

糖尿病 医学 人口 2型糖尿病 疾病 人口学 老年学 环境卫生 内科学 内分泌学 社会学
作者
Arvind Kumar,Ruby Gangwar,Abrar Ahmad Zargar,Ranjeet Kumar,Amit Sharma
出处
期刊:Current Diabetes Reviews [Bentham Science Publishers]
卷期号:20 (1) 被引量:126
标识
DOI:10.2174/1573399819666230413094200
摘要

Diabetes is a severe chronic disease that arises when insulin generation is insufficient, or the generated insulin cannot be used in the body, resulting a long-term metabolic disorder. Diabetes affects an estimated 537 million adults worldwide between the age of 20 to 79 (10.5% of all adults in this age range). By 2030, 643 million people will have diabetes globally, increasing to 783 million by 2045. According to the IDF 10th edition, the incidence of diabetes has been rising in South-East Asia (SEA) nations for at least 20 years, and current estimates have outperformed all previous forecasts. This review aims to provide updated estimates and future projections of diabetes prevalence at the national and global levels by using data from the 10th edition of the IDF Diabetes Atlas 2021. For this review, we studied more than 60 previously published related articles from various sources, such as PubMed and Google Scholar, and we extracted 35 studies out of 60. however, we used only 34 studies directly related to diabetes and its prevalence at the global, SEA, and Indian levels. This review article concludes that in 2021 more than 1 in 10 adults worldwide developed diabetes. The estimated prevalence of diabetes in adults (20 to 79 years) has more than tripled since the first edition in 2000, rising from an estimated 151 million (4.6% of the world's population at the time) to 537.5 million (10.5%) of the world's population today. The prevalence rate will be higher than 12.8% by 2045. In addition, this study indicates that the incidence of diabetes in the world, Southeast Asia, and India was 10.5%, 8.8%, and 9.6%, respectively, throughout 2021 and will rise to 12.5%, 11.5%, and 10.9%, respectively by 2045.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Neltharion完成签到,获得积分10
刚刚
独特跳跳糖完成签到 ,获得积分10
1秒前
量子星尘发布了新的文献求助10
1秒前
2秒前
wlnhyF完成签到,获得积分10
3秒前
LELE完成签到 ,获得积分10
3秒前
3秒前
俞孤风完成签到,获得积分10
4秒前
希望天下0贩的0应助鹿璐采纳,获得10
4秒前
4秒前
忧郁的天思完成签到,获得积分20
5秒前
铜锣湾小研仔完成签到,获得积分10
7秒前
yoyo发布了新的文献求助10
8秒前
luoqin完成签到 ,获得积分10
10秒前
自然怀梦完成签到,获得积分10
11秒前
huahua完成签到 ,获得积分10
12秒前
量子星尘发布了新的文献求助10
12秒前
squeak完成签到,获得积分10
13秒前
恩赐解脱完成签到,获得积分10
14秒前
gao完成签到 ,获得积分10
16秒前
11完成签到 ,获得积分10
16秒前
虚心的不二完成签到 ,获得积分10
17秒前
yuli完成签到 ,获得积分10
17秒前
nature完成签到,获得积分10
18秒前
jiayoujijin完成签到 ,获得积分10
22秒前
小白完成签到,获得积分20
22秒前
量子星尘发布了新的文献求助10
23秒前
曼冬完成签到,获得积分10
24秒前
满意的醉蝶完成签到,获得积分10
24秒前
24秒前
yoyo完成签到,获得积分10
27秒前
cathy-w完成签到,获得积分10
28秒前
du2002完成签到,获得积分10
31秒前
李佳倩完成签到 ,获得积分10
32秒前
小蘑菇应助周芷卉采纳,获得10
33秒前
量子星尘发布了新的文献求助10
33秒前
Zlinco完成签到,获得积分10
33秒前
33秒前
Hastur00完成签到,获得积分10
36秒前
向天歌完成签到,获得积分20
37秒前
高分求助中
Production Logging: Theoretical and Interpretive Elements 2700
Neuromuscular and Electrodiagnostic Medicine Board Review 1000
Statistical Methods for the Social Sciences, Global Edition, 6th edition 600
こんなに痛いのにどうして「なんでもない」と医者にいわれてしまうのでしょうか 510
ALUMINUM STANDARDS AND DATA 500
Walter Gilbert: Selected Works 500
岡本唐貴自伝的回想画集 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3666519
求助须知:如何正确求助?哪些是违规求助? 3225517
关于积分的说明 9763352
捐赠科研通 2935362
什么是DOI,文献DOI怎么找? 1607648
邀请新用户注册赠送积分活动 759289
科研通“疑难数据库(出版商)”最低求助积分说明 735214